Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 71.039B	--
Feb 13, 2025	2025/Q3	-- / 68.957B	--
Nov 12, 2024	2025/Q2	60.838B / 59.733B	--
Aug 8, 2024	2025/Q1	62.566B / 61.500B	--
May 14, 2024	2024/Q4	59.609B / 61.606B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 71.039B--

Feb 13, 20252025/Q3-- / 68.957B--

Nov 12, 20242025/Q260.838B / 59.733B--

Aug 8, 20242025/Q162.566B / 61.500B--

May 14, 20242024/Q459.609B / 61.606B--

Unlock Free Earnings Estimates

Open Account

TOWA Pharmaceutical Earnings Reports

TOWA Pharmaceutical: Confirmation letter

Nov 12 19:01 ET

TOWA Pharmaceutical: Half-Year Report - 69th Term (2024/04/01 - 2025/03/31)

Nov 12 19:00 ET

TOWA Pharmaceutical: Supplementary explanation of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3

Nov 12 01:30 ET

TOWA Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)

Nov 12 01:30 ET

Symbol Price % Chg

Beauty Kadan Holdings

3041

417 +23.74%